VeriSim Life Receives Two Major Accolades in November

What a tremendous quarter it has been for Serra III and SBIC company VeriSIM Life - the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development.

Within the same week in November, the company announced it had won two major accolades. The company was named “Predictive Analytics Solution of the Year” at the 2023 BioTech Breakthrough Awards on November 9. This is the second year in a row that VeriSIM has received this award in the same category. BioTech Breakthrough is a leading independent marketing intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products, and services around the globe.

On November 14, VeriSIM announced its Founder and CEO, Jo Varshney, has been awarded the Gold Stevie® Award in the healthcare category in the 20th annual Stevie Awards for Women in Business. The Stevie Awards honor the world's top women entrepreneurs, executives, employees, and the organizations they run. This year's Stevie Awards for Women in Business received more than 1,600 nominations by organizations and individuals for consideration across 100 categories.

Jo enthused “I am honored to be chosen as the 2023 recipient of the Gold Stevie Award alongside so many influential women in the healthcare field from all over the world. This award is a testament to each woman who has dedicated their lives to innovation in the healthcare industry.”

We are a firm believer in the team at VeriSIM and their innovative solution for solving complex problems in drug development. Our hat's off to you, Jo! Proud to be your partner in changing the world.